{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":31,"n_cols":5,"rows_kept":31,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[16,2,16,3],[17,2,17,3],[18,2,18,3],[19,2,19,3],[20,2,20,3],[24,2,24,3],[25,2,25,3],[29,2,29,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990009818030403321"]
[null,null,"Autore",null,"Cereghino, Mario J."]
[null,null,"Titolo",null,"Il golpe inglese : [da Matteotti a Moro : le prove della guerra segreta per il controllo del petrolio e dell'Italia] / Mario José Cereghino, Giovanni Fasanella"]
[null,null,"Pubbl/distr/stampa",null,"Milano, : Chiarelettere, 2011"]
[null,null,"ISBN",null,"978-88-6190-131-5"]
[null,null,"Descrizione fisica",null,"354 p. ; 21 cm"]
[null,null,"Collana",null,"Principio attivo"]
[null,null,"Disciplina",null,"945.092"]
[null,null,"Locazione",null,"BFS"]
[null,null,"Collocazione",null,"DIC / CER 1"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910253860803321"]
[null,null,"Titolo",null,"Human iPS Cells in Disease Modelling / / edited by Keiichi Fukuda"]
[null,null,"Pubbl/distr/stampa",null,"Tokyo : , : Springer Japan : , : Imprint : Springer, , 2016"]
[null,null,"ISBN",null,"4-431-55966-3"]
[null,null,"Edizione",null,"[1st ed. 2016.]"]
[null,null,"Descrizione fisica",null,"1 online resource (102 p.)"]
[null,null,"Disciplina",null,"570"]
[null,null,"Soggetti",null,"Stem cells"]
[{"$nulls":4},"Cell culture"]
[{"$nulls":4},"Stem Cells"]
[{"$nulls":4},"Cell Culture"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters."]
[null,null,"Nota di contenuto",null,"Chapter 1 Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease -- Chapter 2 Cardiomyopathy -- Chapter 3 Modelling Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy with Patient-specific iPSCs -- Chapter 4 Cardiac Arrhythmia Modelling Using iPS Cells -- Chapter 5 iPSC Disease Modeling of Laminopathies -- Chapter 6 Hematological Disorders -- Chapter 7 Inherited Metabolic Disorders of the Liver. ."]
[null,null,null,"Sommario/riassunto","Human iPS cells have a great potential to be cell sources for regenerative medicine because of the promise of infinite self-renewal and the capability to differentiate into multiple cell types. This book focuses on another great potential of human iPS cells, which is the establishment of human disease models using patient-specific iPS cells. Human iPS cells can be easily obtained from a patient’s somatic cells and provide the entire information on the patient’s genome. Accordingly, we can generate disease models for inheritable diseases in cell culture dishes using iPS cells. This is a quite new technique but holds tremendous potential for our increased understanding of pathogenesis, and will then be the basis for novel drug development industries. All the authors are leading researchers in this field and they have reported many kinds of patient-derived iPS cells. In this book, they introduce the aspects that could be recapitulated in terms of disease modelling as well as further innovative findings such as novel pathogenetic insights and novel therapies. ."]